14
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Signaling Pathways of Mechanotransduction in Arteriolar Endothelium and Smooth Muscle Cells in Hypertension

Pages 277-294 | Published online: 10 Jul 2009

REFERENCES

  • Allen SP, Wade SS, Prewitt RL. (1997). Myogenic tone attenuates pressure-induced gene expression in isolated small arteries. Hypertension 30\(part 1): 203–208.
  • Arnal J-F, Yamin J, Dockery S, Harrison DG. (1994). Regulation of endothelial nitric oxide syn-thase mRNA, protein, and activity during cell growth. Am J Physiol 267\(pt 1):C1381–C1388.
  • Altura, BM. (1975). Sex and estrogens and respon-siveness of terminal arterioles to neurohypophysial hormones and catecholarnines. J Pharmacol Exp Ther 193:403–412.
  • Amer A, Malrnvist U, Uvelius B. (1984). Structural and mechanical adaptations in rat aorta in response to sustained changes in arterial pressure. Acta Phys-iol Scand 122:119–126.
  • Bakker ENTP, Kerkhof CJM, Sipkema P. (1999). Signal transduction in spontaneous myogenic tone in isolated arterioles from rat skeletal muscle. Car-diovasc Res 41:229–236.
  • Bian K, Bukoski RD. (1995). Myofidament calcium sensitivity of normotensive and hypertensive resis-tance arteries. Hypertension 25:110–116.
  • Boegehold MA. (1992). Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats. Hypertension 19:290–295.
  • Bohlen HG. (1979). Arteriolar closure mediated by hyperresponsiveness to norepinephrine in hyperten-sive rats. Am J Physiol 236(5): H157–H164.
  • Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. (1995). Lack of evidence for linkage of the endothelial cell nitric oxide syn-thase gene to essential hypertension. Circulation 91:L96–L102.
  • Brosnihan KB, Moriguchi A, Nakamoto H, Dean RH, Ganten D, Ferrario CM. (1994). Estrogen aug-ments the contribution of nitric oxide to blood pres-sure regulation in transgenic hypertensive rats ex-pressing the mouse Ren-2 gene. Am J Hypertension 7:576–582.
  • Bolz SS, de Wit C, Pohl U. (1999). Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels. Br J Pharmacol 128:124–134.
  • Bryan RM Jr, Maffei& SP, Steenberg ML, Schildm-eyer LA, Johnson TD. (2001). The effects of luminal shear stress on cerebral arteries and arterioles. Am J Physiol 280:H2011–H2022.
  • Bund SJ, West KP, Heagerty AM. (1991). Effects of protection from pressure on resistance artery mor-phology and reactivity in spontaneously hyperten-sive and WKY rats. Circ Res 68:1230–1240.
  • Cardillo C, Kidcoyne CM, Quyyurni AA, Cannon RO, Panza JA. (1998). Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodidation in patients with essential hy-pertension. Circulation 97:851–856.
  • Cernadas MR, de Miguel LS, Garcia-Duran M, Gonzalez-Fernandez F, Millas I, Monton M, Rodrigo J, Rico L, Fernandez P, de Frutos T, Rodriguez-Feo JA, Guerra J, Cararnelo C, Casado S, Lopez-Farre A. (1998). Expression of constitutive and inducible ni-tric oxide synthases in the vascular wall of young and aging rats. Circ Res 83:279–286.
  • Chou, Tz-C, Yen M-H, Li C-Y, Ding Y-A. (1998). Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 3: 643–648.
  • Cohen, RA, Weisbrod BM, Gericke M, Yaghoubi M, Bierl C, and Bolotina VM. (1999). Mechanism of nitric oxide-induced vasodilatation: refilling of in-tracellular stores by sarcoplasmic reticulurn Ca2+ ATPase and inhibition of store-operated Ca2+ in-flux. Circ Res 84:210–219
  • Colburn P, Buonassisi V. (1978). Estrogen-binding sites in endothelial cell cultures. Science 201:817–819.
  • Cosentino F, Katu sic ZS. (1995). Tetrahydrobiop-terin and dysfunction of endothelial nitric oxide syn-thase in coronary arteries. Circulation 91:139–144.
  • D'Angelo G, Davis MJ, Meininger GA. (1997). Cal-cium and mechanotransduction of the myogenic re-sponse. Am J Physiol 273:H175–H182.
  • Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA. (2001). Integrins and mechanotransduction of the vascular myogenic re-sponse. Am J Physiol Heart Circ Physiol 280:H1427–H1433.
  • DeBruyn VH, Nuno DW, Capelli-Bigazzi M, Dole WP, Larnping KG. (1994). Effect of acute hyper-tension in the coronary circulation: role of mechani-cal factors and oxygen radicals. J Hypertension 12(2):163–172.
  • DeLano FA, Schmid-Schöenbein GW. 2001. Visu-alization of oxidative stress enzyme markers within a microvascular network. Proceedings of the 7th World Congress for Microcirculation, Sidney, Aus-tralia.
  • DeLano, FA, Schmid-Schöenbein GW, Skalak TC, Zweifach BW. (1991). Penetration of the systemic blood pressure into the microvasculature of rat skel-etal muscle. Microvasc Res 41:92–110.
  • Dietrich HIFI, Kimura M, Dacey RG Jr. (1994). N-w-nitro-L-arginine constricts cerebral arterioles with-out increasing intracellular calcium levels. Am J Physiol 266:H1681–H1686.
  • Douglas SA, Gellai M, Ezekiel M, Ohlstein EH. (1994). BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in differ-ent rat models of hypertension. J Hypertension 12: 561–567.
  • Dutrait N, Culcasi M, Cazevieille C, Pietri S, Tordo P, Bonne C, Muller A. (1995). Calcium-dependent free radical generation in cultured retinal neurons injured by kainate. Neurosci Lett 198(1):13–16.
  • Falcone JC, Granger HJ, Meininger GA. (1993). En-hanced myogenic activation in skeletal muscle arte-rioles from spontaneously hypertensive rats. Am J Physiol 265:H1847–H1855.
  • Falcone JC, Meininger GA. (1999). Endothelin me-diates a component of the enhanced myogenic re-sponsiveness of arterioles from hypertensive rats. Microcirculation 6:305–313.
  • Farhat MY, Lavigne MC, Rarnwell PW. (1996). The vascular protective effects of estrogen. FASER J 10: 615–624.
  • Folkow B. (1989). Functional and structural "auto-regulation": some personal considerations concern-ing the century-old development of these microvas-cular concepts. Micro vasc Res 37:243–255.
  • Fu-Xiang D, Jameson M, Skopec J, Diederich A, Diederich D. (1992). Endothelial dysfunction of re-sistance arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol 20:S190–S192.
  • Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM. (1995). Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H syn-thase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76:1003–1010.
  • Gokina NI, Knot HJ, Nelson MT, Osol G. (1999). Increased Ca2+ sensitivity as a key mechanism of PKC -induced constriction in pressurized cerebral arteries. Am J Physiol 277:H1178–H1188.
  • Gokina NI, Osol G. (1998). Temperature and pro-tein kinase C modulate myofilarnent Ca2+ sensitivity in pressurized rat cerebral arteries. Am J Physiol 274:H1920–H1927.
  • Gorlach C, Benyo Z, Wahl M. (1998). Endothelin-1-induced contraction in cerebral vessels mediated by phospholipase C/protein kinase C cascade. Kid-ney Int (Suppl) 67:S224–S225.
  • Grtmfeld S, Hamilton CA, Mesaros S, McLain SW, Dominiczak AF, Bohr DF, Malinski T. (1995). Role of superoxide in the depressed nitric oxide produc-tion by the endothelium of genetically hypertensive rats. Hypertension 26 (part 1):854–857.
  • Gura T. (1995). Estrogen: key player in heart dis-ease among women. Science 269:771–773.
  • Hajdu MA, Rodenburg JM, Kaley G, Koller A. (1993). Effects of hypertension on sensitivity of ar-teriolar smooth muscle to endothelium derived va-sodilator factors. FASER J 7(4):A557(#3230).
  • Harder DR, Sanchez-Ferrer C, Kauser K, Stekiel WJ, Rubanyi GM. (1989). Pressure releases a trans-ferable endothelial contractile factor in cat cerebral arteries. Circ Res 56:193–198.
  • Hayashi K, Epstein M, Loutzenhiser R. (1992). En-hanced myogenic responsiveness of renal interlobu-lar arteries in spontaneously hypertensive rats. Hy-pertension 19:153–160.
  • Henriksen O, Skagen K, Amtorp O, Harding O. (1981 ) . Augmented vasoconstrictor response to changes in vascular transmural pressure in patients with essential arterial hypertension. Acta Physiol Scand 112:323–329.
  • Henrion D, Benessiano J, Levy BI. (1997). In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor ar-tery. Circ Res 80:189–195.
  • Henrion, D, Iglarz, M, Levy, BI. (1999). Chronic endothelin-1 improves nitric oxide-dependent flow-induced dilation in resistance arteries from normo-tensive and hypertensive rats. Arterioscler Thromb Vasc Biol 19:2148–2153.
  • Heog ym, Willis LR, Weinberger M H. (1977). Es-trogen attenuation of the development of hyperten-sion in spontaneous hypertension rats. Am J Physiol 233:H369–H373.
  • Hill MA, Zou H, Davis MJ, Potocnik SJ, Price S. (2000). Transient increases in diameter and [Ca2+]1 are not obligatory for myogenic constriction. Am J Physiol Heart Circ Physiol 278:H345–H352.
  • Hirata MK, Kohse P, Chang CH, Ikebe T, Murad F. (1990). Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem 265:1268–1273.
  • Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. (1992). Transmural pressure inhibits nitric oxide release from human endothelial cells. Eur J Phar-macol 215:329–331.
  • Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, Wang DL. (1998). Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expres-sion. J Cell Physiol 175:156–162.
  • Huang A, Sun D, Koller A. (1993). Endothelial dys-function augments myogenic arteriolar constriction in hypertension. Hypertension 22:913–921.
  • Huang A, Koller A. (1996). Both nitric oxide and prostaglandin-mediated responses are impaired in skeletal muscle arterioles of hypertensive rats. Hy-pertension 14:887–895.
  • Huang A, Koller A. (1997). Endothelin and prosta-glandin H2 enhance arteriolar myogenic tone in hy-pertension. Hypertension 30:1210–1215.
  • Huang A, Sun D, Kaley G, Koller A. (1998). Super-oxide released to high intra-arteriolar pressure re-duces nitric oxide-mediated shear stress-and ago-nist-induced dilations. Circ Res 83(9):960–965.
  • Huang A, Sun D, Koller A. (2000). Shear stress-induced release of prostaglandin H2 in arterioles of hypertensive rats. Hypertension 35:925–930.
  • Huang A, Sun D, Kaley G, Koller A. (1997). Estro-gen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension 29:1351–1356.
  • Huang, A, Sun D, Kaley G, Koller A. (1998). Estro-gen preserves regulation of shear stress by nitric ox-ide in arterioles of female hypertensive rats. Hyper-tension 31\(part 2):309–314.
  • Hutchins PM, Lynch CD, Cooney PT, Curseen KA. (1996). The microcirculation in experimental hy-pertension and aging. Cardiovasc Res 32:772–780.
  • Jams SG, Wexler BC. (1979). Inhibition of the de-velopment of spontaneous hypertension in SH rats by gonadectomy or estradiol. J Lab Clin Med 10: 608–616.
  • Ishii K, Suita S, Surnirnoto H. (1990). Effect of ve-rapamil on conversion of xanthine dehydrogenase to oxidase in ischemic rat liver. Res Exp Med 190(6): 389–399.
  • Izzard AS, Bund SJ, Heagerty AM. (1996). Myo-genic tone in mesenteric arteries from spontaneously hypertensive rats. Am J Physiol 270:H1–H6.
  • Jacinto SM, Jandhyala BS. (1992). Evaluation of the effect of felodipine, veraparnil and hydralazine on the survival rate of rats subjected to lethal effect of oxygen free radicals. Naunyn Scmiedebergs Arch Pharmacol 346(4) :457–461.
  • Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. (1992). Acute effect of 1713 -estradiol on rabbit coro-nary artery contractile responses to endothelin-1. Am J Physiol 263 (32 ) :H271–H275.
  • Johnson PC. (1989). The myogenic response in the microcirculation and its interaction with other con-trol systems. J Hypertension (Suppl.) 7:S33–S39.
  • Karibe A, Watanabe J, Horiguchi S, Takeuchi M, Suzuki S, Funakoshi M, Katoh H, Keitoku M, Satoh S, Shirato K. (1997). Role of cytosolic Ca2+ and protein kinase C in developing myogenic contraction in isolated rat small arteries. Am J Physiol 272:H1165–H1172.
  • Kauser K, Rubanyi GM. (1994). Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 267(36): H2311–H2317.
  • Kirton CA, Loutzenhiser R. (1998). Alterations in basal protein kinase C activity modulate renal affer-ent arteriolar myogenic reactivity. Am J Physiol 275:H467–H475.
  • Kitazawa T, Eto M, Woodsome TP, Brautigan DL. (2000). Agonists trigger G protein-mediated activa-tion of the CPI-17 inhibitor phosphoprotein of myo-sin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275:9897–9900.
  • Knot HJ, Nelson MT. (1998). Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508:199–209.
  • Kurata R, Takayanagi I, Hisayarna T. (1993). Eico-sanoid-induced Ca2+ release and sustained contrac-tion in Ca2+-free media are mediated by different signal transduction pathways in rat aorta. Br J Pharmacol 110:875–881.
  • Koller A, Huang A. (1995). Shear stress-induced dilation is attenuated in skeletal muscle arterioles of hypertensive rats. Hypertension 25 (part 2):758–763.
  • Koller A, Kaley G. (1996). Shear stress dependent regulation of vascular resistance in health and dis-ease: role of endothelium. Endothelium 4:247–272.
  • Koller A, Huang A. (1994). Impaired nitric oxide-mediated flow-induced dilation in arterioles of spon-taneously hypertensive rats. Circ Res 74:416–421.
  • Koller A, Huang A. (1999). Development of nitric oxide and prostaglandin mediation of shear stress-induced arteriolar dilation with aging and hyperten-sion. Hypertension 34:1073–1079.
  • Koller A, Huang A. (2002). Xanthine oxidase-derived superoxide release to high intraarteriolar pressure impairs nitric oxide-mediated flow induced dilation. FASER J 16(4 ) :A428 (#378.1 ) .
  • Koller A, Sun D, Kaley G. (1993). Role of shear stress and endothelial prostaglandins in flow-and viscosity-induced dilation of arterioles in vitro. Circ Res 72:1276–1284.
  • Koller A, Sun D, Huang A, Kaley G. (1994). Core-lease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arte-rioles. Am J Physiol 267:H326–H332.
  • Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. (1998). The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hy-pertension Investigators. N Engl J Med 338:784–790.
  • Kuo L, Davis MJ, Chilian W1VI. (1990). Endothe-lium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 259:H1063–H1070.
  • Laasko J, Mervaala E, Hirnberg JJ, Teravained TL, Karppanen H, Vapaatalo H, Lapatto R. (1998). In-creased kidney xanthine oxidoreductase activity in salt induced experimental hypertension. Hyperten-sion 32:902–906.
  • Laursen JB, Rajagopalan S, Galls Z, Tarpey M, Freeman BA. Harrison DG. (1997). Role of super-oxide in angiotensin II-induced but not catechol-amine -induced hypertension. Circulation 95 (3 ) : 588–593.
  • Lauth M, Berger M, Cattaruzza M, Hecker M. (2000). Elevated perfusion pressure upregulates en-dothelin-1 and endothelin B receptor expression in the rabbit carotid artery. Hypertension 35:648–654.
  • Lee MR, Li L, Kitazawa T. (1997). Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phos-phatase. J Biol Chem 272:5063–5068.
  • Lemne CE, Lundeberg T, Theodorsson E, de Faire U. (1994). Increased basal concentrations of plasma endothelin in borderline hypertension. J Hyperten-sion 12:1069–1074.
  • Le Noble JLML, Tangelder GJ, Slaaf DW, van Essen H, Reneman RS, Struyker-Bedier HA. (1990). A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hy-pertensive rats. J Hypertension 8:741–748.
  • Levy BI, Ambrosio G, Pries AR, Struijker-Boudier H&J. (2001). Microcirculation in hypertension: a new target for treatment? Circulation 104:735–740.
  • Lipowsky FIJI. (1995). Shear stress in the circula-tion. In: Flow-Dependent Regulation of Vascular Function (JA Bevan, G Kaley, GM Rubani, Eds.). Oxford University Press. New York.
  • Madden JA, Christman NJ. (1999). Integrin signal-ing, free radicals, and tyrosine kinase mediate flow constriction in isolated cerebral arteries. Am J Phys-iol 277:H2264–H2271.
  • Malinski T, Kapturczak M, Dayharsh J, Bohr D. (1993). Nitric oxide synthase activity in genetic hy-pertension. Biochem Biophys Res Commun 194: 654–658.
  • Matrougui K, Jacques M, Levy BI, Henrion D. (1997). Impaired nitric oxide-and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension 30:942–947.
  • Mayhan WG. (1992). Role of prostaglandin H2-thromboxane A2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol 262: H539–H543.
  • Mayrovitz HA-, Roy J. (1983). Microvascular blood flow: evidence indicating a cubic dependence on ar-teriolar diameter. Am J Physiol 245:H1031–H1038.
  • McMahon EG, Palomo MA, Brown MA, Bertenshaw SR, Carter JS. (1993). Effect of phosphorarnidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. Am J Hyperten-sion 6:667–673.
  • Moncada S, Higgs A. (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012.
  • Moreau P. (1998). Endothelin in hypertension: a role for receptor antagonists? Cardiovasc Res 39: 534–542.
  • Mulvany MJ. (1990). Structure and function of small arteries in hypertension. J Hypertension Suppl 8:S225–S232.
  • Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, wu KK, Szklo M. (1993). Association of hor-mone-replacement therapy with various cardiovas-cular risk factors in postmenopausal women. N Engl J Med 328:1069–1075.
  • Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. (1991). Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88:10045–10048.
  • Newaz MA, Adeeb NN, Muslim N, Razak TA, Htut NN. (1996). Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive sub-jects. Clin Exp Hypertension 18(8):1035–1050.
  • Nishikawa Y, Stepp DW, Chilian W1VI. (2000). Ni-tric oxide exerts feed back inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol 279(2):H459–H465.
  • Nishimura J, Breemen C. (1989) Direct regulation of smooth muscle contractile elements by second mes-sengers. Biochem Biophys Res Commun 163:929–935.
  • Node K, Kitakaze M, Yoshikawa H, Kosaka H, Honi M. (1997). Reduced plasma concentrations of nitro-gen oxide in individuals with essential hypertension. Hypertension 30\(part 1):405–408.
  • Norrelund, H. Christensen KL, Sarnani NJ, Kirnber P, Mulvany MJ, Korsgaard N. (1994). Early nar-rowed afferent arteriole is a contributor to the de-velopment of hypertension. Hypertension 24:301–308.
  • Obara K, Hata S, Sato K, Koide M, Ishii K, Na-kayama K. (1999). Contractile potentiation by en-dothelin-1 involves protein kinase C-b activity in the porcine coronary artery. Jpn J Physiol 49:175–183.
  • Osol G. (1995). Mechanotransduction by vascular smooth muscle. J Vasc Res 32:275–292.
  • Osol G, Laher I, Cipolla M. (1991). Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 68:359–367.
  • Osol G, Halpern W. (1985). Myogenic properties of cerebral blood vessels from normotensive and hy-pertensive rats. Am J Physiol 249:H914–H921.
  • Panza JA, Quyyurni AA, Callahan TS, Epstein SE. (1993). Effect of antihypertensive treatment on en-dothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 21(5):1145–1151.
  • Parkington HC, Tare M, Tonta MA, Coleman HA. (1993). Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J Physiol 465:459–476.
  • Prewitt RL, Wang DH, Hill MA. (1994). The patho-physiology of the microcirculation In: Hypertension (NA Mortillaro, AE Taylor, Eds.) CRC Press. Boca Raton, FL, 61–86.
  • Qiu, HY, Henrion, D, Benessiano, J, Heymes, C, Tournier, B, Levy, BI. (1998). Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats. Hypertension 32:1098–1103.
  • Rajagopalan S, Kurz S, Munzel T, Tarpey M, Free-mena BA, Grindling KK, Harrison DG. (1996). An-giotensin II-mediated hypertension in rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest 97: 1916–1923.
  • Rizzoni D, Porteri E, Castellano M, Bettoni G, Muie-san ML, Tiberio G, Giulini SM, Rossi G, Bernini G, Agabiti-Rosei E. (1998). Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 31\(part 2): 335–341.
  • Rosselli M, Irnthurn B, Keller PJ, Jacson EK, Dubey RK. (1995). Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17-Pestradiol and norethisterone acetate: a two-year follow-up study. Hypertension 25 (part 2):848–853.
  • Roy JW, and Mayrovitz FIN. (1984). Microvascular pressure, flow and resistance in spontaneously hy-pertensive rats. Hypertension 6:877–886.
  • Rubanyi GM, Freay AD, Johns A, Van Breeman C. (1991). Elevated transmural pressure inhibits the release of EDRF by mechanism(s) similar to high IC+ and barium. In: Resistance Arteries, Structure and Function (Mulvany MJ, Aalkjaer C, Heagerty AM, Nyborg NCB, Strandgaard S., Eds.) Elsevier Sci-ence. Amsterdam.
  • Ryan SM, Waack BJ, Weno BL, Heistad DD. (1995). Increase in pulse pressure impair acetylcholine-induced vascular relaxation. Am J Physiol 37:H359–H363.
  • Sasajirna H, Shirna H, Toyoda Y, Kimura K, Yoshi-kawa A, Hano T, Nishio I. (1997). Increased Ca2+ sensitivity of contractile elements via protein kinase C in et-toxin permeabilized SMA from young spon-taneously hypertensive rats. Cardiovasc Res 36:86–91.
  • Schiffrin EL, Deng LY, Sventek P, Day R. (1997). Enhanced expression of endothelin-1 gene in resis-tance arteries in severe human essential hyperten-sion. J Hypertension 15:57–63.
  • Schiffrin EL, Thibault G. (1991). Plasma endothe-lin in human essential hypertension. Am J Hyper-tension 4:303–308.
  • Schmid-Schoenbein GW, Seiffge D, Delano FA, Shen K, Zweifach BW. (1991). Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 17(3):323–330.
  • Skov K, Fenger-Gron J, Mulvany MJ. (1996). Ef-fects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure. Hy-pertension 28:464–471.
  • Smiesko V, Lang DJ, Johnson PC. (1989). Dilator response of rat mesenteric arcading arterioles to in-creased blood flow velocity. Am J Physiol 257(26): H1958–H1965.
  • Soloviev AT, Bershtein SA. (1992). The contractile apparatus in vascular smooth muscle cells of spon-taneously hypertensive rats possess increased cal-cium sensitivity: the possible role of protein kinase C. J Hypertension 10:131–136.
  • Sudhir K, Jennings GL, Funder JW, Komesaroff PA. (1996). Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension 28:330–334.
  • Sun D, Kaley G, Koller A. (1994). Characteristics and origin of myogenic response in isolated gracilis muscle arterioles. Am J Physiol 266:H1177–H1183.
  • Suzuki H, Zweifach BW, Schmid-Schoenbein GW. (1996). Glucocorticoid modulates vasodilator re-sponse of mesenteric arterioles in spontaneously hy-pertensive rats. Hypertension 27:114–118.
  • Suzuki H, DeLano FA, Parks DA, Jarnshidi N, Granger DN, Ishii H, Suematus M, Zweifach BW, Schmid-Schoenbein GW. (1998). Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 95:4754–4759.
  • Suzuki H, Swei A, Zweifach BW, Schmid-Schöenbein GW. (1995). In vivo evidence for mi-crovascular oxidative stress in spontaneously hyper-tensive rats: hydroethidine micro/fluorography. Hy-pertension 25:1083–1089.
  • Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. (1997). Oxidative stress in the Dahl hyperten-sive rat. Hypertension 30:1628–1633.
  • Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A. (1999). Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circula-tion of patients with essential hypertension. Circu-lation 100:1680–1683.
  • Tesfarnariarn B, Halpern W. (1988). Endothelium-dependent and endothelium-independent vasodila-don in resistance arteries from hypertensive rats. Hypertension 11:440–444.
  • Tran, NN, Spitzbarth E, Robert A, Giurnrnelly P, Atkinson J, Capdeville-Atkinson C. (1998). Nitric oxide lowers the calcium sensitivity of tension in the rat tail artery. J Physiol 507:163–174.
  • Twort, CH, van Breemen C. (1988). Cyclic guano-sine monophosphate-enhanced sequestration of Ca2+ by sarcoplasmic reticulurn in vascular smooth muscle. Circ Res 62:961–964.
  • Ungvari Z, Pacher P, Kecskemeti V, Papp G, Szollar L, Koller A. (1999). Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C. Cardiovasc Res 43: 1018–1028.
  • Ungvari Z, Koller A. (2000). Endothelin and PGH2/ TXA2 enhances myogenic constriction in hyperten-sion by increasing Ca2+ sensitivity of arteriolar smooth muscle. Hypertension 36:856–861.
  • Ungvari Z, Koller A. (2001). Hypertension enhances gap junctions-mediated arteriolar myoendothelial coupling. Circulation 104.
  • Ungvari Z, Koller A. (2001). NO released to flow induces myogenic tone of skeletal muscle arterioles by decreasing smooth muscle Ca2+ sensitivity. J Appl Physiol 91:522–527.
  • Ungvari Z, Koller A. (2001). Mediation of EDHF-induced reduction of smooth muscle [Ca2]i and ar-teriolar dilation by IC+ channels, 5,6-EET, and gap junctions. Microcirculation 8:265–274.
  • Ungvari Z, Sun D, Huang A, Kaley G, Koller A. (2001). Role of endothelial [Ca2]i in activation of eNOS in pressurized arterioles by agonists and wall shear stress. Am J Physiol Heart Circ Physiol 281:H606–H612.
  • Ungvari Z, Koller A. (2000). Endothelin and pros-taglandin H2/thromboxane A2 enhance myogenic constriction in hypertension by increasing Ca2+ sen-sitivity of arteriolar smooth muscle. Hypertension 36:856–861.
  • Ungvari Z, Csiszar A, Koller A. (2002) Endothelial [Ca2]i activates Ka channels and via gap junctions elicits EDHF-type arteriolar dilation. Am J Physiol Heart Circ Physiol 282:H1760–H1767.
  • VanBavel E, Wesselrnan JP, Spaan JA. (1998). Myo-genic activation and calcium sensitivity of cannu-lated rat mesenteric small arteries. Circ Res 82:210–220.
  • Verdecchia P, Schillaci G, Reboldi GP, Santeusanio F, Porcellati C, Brunetti P. (2000). Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIMA study. Hyper-tension 36:1072–1078.
  • Walsh BW, Schiff I, Rosner B, Greenber L, Ravnikar V, Sacks FM. (1991). Effects of postmenopausal es-trogen replacement on the concentration and me-tabolism of plasma lipoproteins. N Engl J Med 325: 1196–1204.
  • Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L. (2001). Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hyper-tension 37:1069–1074.
  • Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. (1994). Induction of cal-cium-dependent nitric oxide synthases by sex hor-mones. Proc Natl Acad Sci USA 91:5212–5216.
  • White RE, Darkow DJ, Falvo Lang JL. (1995). Es-trogen relaxes coronary arteries by opening BKCa+ channels through a cGMP-dependent mechanism. Circ Res 77(5):936–942.
  • William SP, Shackford DP, Jams SG, Mustafa SJ. (1988). Endothelium dependent relaxation in estro-gen-treated spontaneously hypertensive rats. Eur J Pharmacol 145:205–207.
  • Xia Y, Tsai AL, Berka V, Zweier JL. (1998). Super-oxide generation from endothelial nitric oxide syn-thase. J Biol Chem 273(40):25804–25808.
  • Zou H, Ratz PH, Hill MA. 1995). Role of myosin phosphorylation and [Ca2+], in myogenic reactivity and arteriolar tone. Am J Physiol 269:H1590–H1596.
  • Yanagisawa T, Kawada M, Taira N. (1989). Nitro-glycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concen-trations measured with fura-2. Br J Pharmacol 98: 469–482.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.